8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine

C113H98ClF10N25O4S2 — CID 161077756

About 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine

8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine (PubChem CID 161077756) has the molecular formula C113H98ClF10N25O4S2 and a molecular weight of 2159.76 g/mol. Its IUPAC name is 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine.

Molecular Properties

• Compound Name: 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine
• PubChem CID: 161077756
• Molecular Formula: C113H98ClF10N25O4S2
• Molecular Weight: 2159.76 g/mol
• Exact Mass: 2157.72
• IUPAC Name: 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine
• SMILES: C#CCOc1cnc(C(=O)Cc2cc(F)c(F)c([C@@]3(C)N=C(N)C[C@H]4C[C@H]43)c2)cn1.COC[C@]12C[C@H]1[C@@](C)(c1cc(Cc3nccc4cc(C#N)cnc34)cc(F)c1F)N=C(N)S2.COC[C@]12C[C@H]1[C@@](C)(c1cc(Cc3ncnc4cc(Cl)cnc34)cc(F)c1F)N=C(N)S2.C[C@]1(c2cc(Cc3ncnc4cc(C#N)cnc34)cc(F)c2F)N=C(N)C[C@H]2C[C@H]21.N#Cc1cnc2c(Cc3ccc(F)c([C@@]4(CF)N=C(N)C[C@H]5C[C@H]54)c3)nccc2c1
• InChI: InChI=1S/C24H21F2N5OS.C23H19F2N5.C22H20ClF2N5OS.C22H18F2N6.C22H20F2N4O2/c1-23(19-9-24(19,12-32-2)33-22(28)31-23)16-6-13(7-17(25)20(16)26)8-18-21-15(3-4-29-18)5-14(10-27)11-30-21;24-12-23(17-8-16(17)9-21(27)30-23)18-6-13(1-2-19(18)25)7-20-22-15(3-4-28-20)5-14(10-26)11-29-22;1-21(17-7-22(17,9-31-2)32-20(26)30-21)13-3-11(4-14(24)18(13)25)5-15-19-16(29-10-28-15)6-12(23)8-27-19;1-22(14-6-13(14)7-19(26)30-22)15-2-11(3-16(23)20(15)24)4-17-21-18(29-10-28-17)5-12(8-25)9-27-21;1-3-4-30-20-11-26-17(10-27-20)18(29)7-12-5-15(21(24)16(23)6-12)22(2)14-8-13(14)9-19(25)28-22/h3-7,11,19H,8-9,12H2,1-2H3,(H2,28,31);1-6,11,16-17H,7-9,12H2,(H2,27,30);3-4,6,8,10,17H,5,7,9H2,1-2H3,(H2,26,30);2-3,5,9-10,13-14H,4,6-7H2,1H3,(H2,26,30);1,5-6,10-11,13-14H,4,7-9H2,2H3,(H2,25,28)/t19-,23+,24+;16-,17-,23+;17-,21+,22+;2*13-,14-,22+/m01011/s1
• InChIKey: UFMVNUQNTKFVGH-OXKQTYBRSA-N
• XLogP: 18.26
• TPSA: 462.71 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 31
• Rotatable Bonds: 23
• Heavy Atoms: 155
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2159.76
LogP ≤ 5	18.26
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	31

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine?

The IUPAC name of 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine (CID 161077756) is 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine.

What is the SMILES notation for 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine?

The canonical SMILES for 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine is C#CCOc1cnc(C(=O)Cc2cc(F)c(F)c([C@@]3(C)N=C(N)C[C@H]4C[C@H]43)c2)cn1.COC[C@]12C[C@H]1[C@@](C)(c1cc(Cc3nccc4cc(C#N)cnc34)cc(F)c1F)N=C(N)S2.COC[C@]12C[C@H]1[C@@](C)(c1cc(Cc3ncnc4cc(Cl)cnc34)cc(F)c1F)N=C(N)S2.C[C@]1(c2cc(Cc3ncnc4cc(C#N)cnc34)cc(F)c2F)N=C(N)C[C@H]2C[C@H]21.N#Cc1cnc2c(Cc3ccc(F)c([C@@]4(CF)N=C(N)C[C@H]5C[C@H]54)c3)nccc2c1.

What is the InChIKey of 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine?

The InChIKey is UFMVNUQNTKFVGH-OXKQTYBRSA-N. The full InChI is InChI=1S/C24H21F2N5OS.C23H19F2N5.C22H20ClF2N5OS.C22H18F2N6.C22H20F2N4O2/c1-23(19-9-24(19,12-32-2)33-22(28)31-23)16-6-13(7-17(25)20(16)26)8-18-21-15(3-4-29-18)5-14(10-27)11-30-21;24-12-23(17-8-16(17)9-21(27)30-23)18-6-13(1-2-19(18)25)7-20-22-15(3-4-28-20)5-14(10-26)11-29-22;1-21(17-7-22(17,9-31-2)32-20(26)30-21)13-3-11(4-14(24)18(13)25)5-15-19-16(29-10-28-15)6-12(23)8-27-19;1-22(14-6-13(14)7-19(26)30-22)15-2-11(3-16(23)20(15)24)4-17-21-18(29-10-28-17)5-12(8-25)9-27-21;1-3-4-30-20-11-26-17(10-27-20)18(29)7-12-5-15(21(24)16(23)6-12)22(2)14-8-13(14)9-19(25)28-22/h3-7,11,19H,8-9,12H2,1-2H3,(H2,28,31);1-6,11,16-17H,7-9,12H2,(H2,27,30);3-4,6,8,10,17H,5,7,9H2,1-2H3,(H2,26,30);2-3,5,9-10,13-14H,4,6-7H2,1H3,(H2,26,30);1,5-6,10-11,13-14H,4,7-9H2,2H3,(H2,25,28)/t19-,23+,24+;16-,17-,23+;17-,21+,22+;2*13-,14-,22+/m01011/s1.

What are the key properties of 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine?

8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine has a molecular weight of 2159.76 g/mol, XLogP of 18.26, 23 rotatable bonds, 5 hydrogen bond donors, and 31 hydrogen bond acceptors.

Where does this data come from?

All data for 8-[[3-[(1R,2S,6R)-4-amino-2-(fluoromethyl)-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4-fluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;8-[[3-[(1S,5S,6S)-3-amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]methyl]-1,7-naphthyridine-3-carbonitrile;4-[[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]methyl]pyrido[3,2-d]pyrimidine-7-carbonitrile;2-[3-[(1R,2S,6R)-4-amino-2-methyl-3-azabicyclo[4.1.0]hept-3-en-2-yl]-4,5-difluorophenyl]-1-(5-prop-2-ynoxypyrazin-2-yl)ethanone;(1S,5S,6S)-5-[5-[(7-chloropyrido[3,2-d]pyrimidin-4-yl)methyl]-2,3-difluorophenyl]-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-3-amine is sourced from PubChem (CID 161077756), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).